Biotech
EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwired) -- 01/04/17 -- (TSX VENTURE: CZO) ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercializ ...
PHILADELPHIA, PA: PHILADELPHIA, PA -- (Marketwired) -- 01/04/17 -- (NASDAQ: GNMX)(NASDAQ: GNMX) (the Company) announced today that enrollment is complete in the SAGA (Study of Adolescent Glutamate Receptor Network Cop ...
HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwired) -- 01/04/17 -- Immunovaccine Inc. (TSX: IMV)(OTCQX: IMMVF), a clinical stage vaccine and immunotherapy company, today announced that it will participate in the ...
GUILDFORD, UNITED KINGDOM: GUILDFORD, UNITED KINGDOM -- (Marketwired) -- 01/04/17 -- Angle PLC (AIM: AGL) (OTCQX: ANPCY)AIM: AGL and OTCQX: ANPCY("ANGLE" or "the Company")ANGLE plc (AIM: AGL and OTCQX: ANPC ...
CITY OF INDUSTRY, CA: CITY OF INDUSTRY, CA -- (Marketwired) -- 01/03/17 -- Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for di ...
EDMONTON, ALBERTA: Presentation with live audio webcast on Monday, January 9th at 3:00 p.m. PT ...
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 01/02/17 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) ("Prima", the "Company") announces that it has developed a new early stage product can ...
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 12/29/16 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) ("Prima" or the "Company") today announced interim data for its TACTI-mel (Two ACTive ...
CITY OF INDUSTRY, CA: CITY OF INDUSTRY, CA -- (Marketwired) -- 12/27/16 -- Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for di ...
SEATTLE, WA: SEATTLE, WA -- (Marketwired) -- 12/23/16 -- Atossa Genetics, Inc. (NASDAQ: ATOS) today announced that Jack Cuzick, PhD, FRS, FMedSci, FRCP (hon), has been appointed as Scientific Advisor.Dr. Cuzick i ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 12/23/16 -- Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company"), an innovator of biological products and technologies, today re ...
LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwired) -- 12/22/16 -- Sernova Corp. (TSX VENTURE: SVA)(OTCQB: SEOVF)(FRANKFURT: PSH), a clinical stage regenerative medicine company, is pleased to announce that Dr. Philip ...
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 12/19/16 --Competent Authority and Ethics Committee approval received in the United Kingdom for AIPACRecruitment of patients in second cohort of AIPAC study compl ...
SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwired) -- 12/19/16 -- , an independent investment publication that highlights important technologies and companies, today released an interview with , CEO of , Inc. (OTCQB: IN ...
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 12/18/16 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) ("Prima", the "Company") announces a ratio change for the Company's American Depo ...
LYON, FRANCE: LYON, FRANCE -- (Marketwired) -- 12/16/16 -- Flamel Technologies SA (NASDAQ: FLML) today announced that the first patient has been dosed in its Rest-On Phase III clinical trial of FT218, a once-night ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 12/16/16 -- IBEX Technologies Inc. ("IBEX" or the "Company") (TSX VENTURE: IBT) today reported its financial results for the quarter ended Oc ...
CITY OF INDUSTRY, CA: CITY OF INDUSTRY, CA -- (Marketwired) -- 12/14/16 -- Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for ca ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 12/13/16 -- Helix BioPharma Corp. (TSX: HBP)(FRANKFURT: HBP), an immuno-oncology company developing drug candidates for the prevention and treatment of cancer, t ...
PALO ALTO, CA: Bioz Anticipates Industry to "Catch Up" in Adopting Trending Technologies to Accelerate Life Science Research in Year Ahead ...
